|
Variables
|
n = 79 (%)
|
3-years OS rate (%)
|
5-year OS rate (%)
|
Pvalue*
| |
|---|
|
Age (years)
| | | | | |
|
<60
|
27 (34.2)
|
70.4
|
63.0
|
0.11
| |
|
≥60
|
52 (65.8)
|
52.5
|
43.1
| | |
|
Gender
| | | | | |
|
Male
|
68 (86.1)
|
58.9
|
50.8
|
0.91
| |
|
Female
|
11 (13.9)
|
57.7
|
46.2
| | |
|
Location
| | | | | |
|
Upper
|
12 (15.2)
|
50.0
|
41.7
|
control
| |
|
Middle
|
47 (59.5)
|
61.0
|
48.2
|
0.76
| |
|
Lower
|
20 (25.3)
|
60.0
|
60.0
|
0.38
| |
|
cT
| | | | | |
|
cT1
|
24 (30.4)
|
85.9
|
76.4
|
control
| |
|
cT2
|
8 (10.1)
|
85.7
|
71.4
|
0.94
| |
|
cT3
|
47 (59.5)
|
41.5
|
34.4
|
0.0006
| |
|
cN
| | | | | |
|
cN0
|
29 (36.7)
|
80.8
|
72.7
|
0.0028
| |
|
cN1-3
|
50 (63.3)
|
47.0
|
38.2
| | |
|
cStage
| | | | | |
|
cStageI
|
22 (27.8)
|
89.5
|
79.0
|
control
| |
|
cStageII
|
17 (21.5)
|
67.0
|
60.3
|
0.25
| |
|
cStageIII
|
40 (50.6)
|
40.0
|
31.8
|
0.0002
| |
|
Clinical course
| | | | | |
|
CR continue
|
35 (44.3)
|
87.5
|
84.1
|
<0.0001
| |
|
Failure
|
44 (55.7)
|
37.3
|
25.5
| | |
- *log-rank test.
- OS, overall survival.
